← All candidates
55 insider filings on record.
55 filings on record.
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
NasdaqGS · Healthcare · $1.43B
$24.08
-4.37% · Sep 16
55 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 30 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.43B
Float
33.3M
56% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
13.4
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Cohen Raymond W
Bought $289.0K on Mar 7 — 17,000 sh @ $17.00, held direct, 57% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
50 more transactions on Pro →Context
Wall St
$27.71 avg target
+15.1% vs today · 7 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.40 act+$0.20
Q4 '25−$0.45 act+$0.11
Q3 '25−$0.36 act+$0.42
Q2 '25−$1.15 act−$0.62
Coverage
Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price WeaknessSimply Wall St. · 03-29Kestra Medical Technologies Q3 Earnings Call HighlightsMarketBeat · 03-18KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call SummaryMoby · 03-18Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ...
The file stays open
55 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice